These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37167705)

  • 41. A reverse method for diversity introduction of benzimidazole to synthesize H(+)/K(+)-ATP enzyme inhibitors.
    Yan Y; Liu Z; Zhang J; Xu R; Hu X; Liu G
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4189-92. PubMed ID: 21684741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacological characteristics and clinical efficacies of a novel potassium-competitive acid blocker, vonoprazan fumarate].
    Matsukawa J; Inatomi N; Nishida H; Tsukimi Y
    Nihon Yakurigaku Zasshi; 2018; 152(3):104-110. PubMed ID: 30185727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of NC-1300-B, a new benzimidazole derivative, on hog gastric H+, K+-ATPase, gastric acid secretion and HCl.ethanol-induced gastric lesions in rats.
    Okabe S; Akimoto Y; Yamasaki S; Nagai H
    Dig Dis Sci; 1988 Nov; 33(11):1425-34. PubMed ID: 2846250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real time measurements of water flow in amphibian gastric glands: modulation via the extracellular Ca2+-sensing receptor.
    Gerbino A; Fistetto G; Colella M; Hofer AM; Debellis L; Caroppo R; Curci S
    J Biol Chem; 2007 May; 282(18):13477-86. PubMed ID: 17363364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of gastric H+,K(+)-ATPase and acid secretion by cassigarol A, a polyphenol from Cassia garrettiana Craib.
    Murakami S; Arai I; Muramatsu M; Otomo S; Baba K; Kido T; Kozawa M
    Biochem Pharmacol; 1992 Jul; 44(1):33-7. PubMed ID: 1321629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole.
    Wallmark B; Sachs G; Mardh S; Fellenius E
    Biochim Biophys Acta; 1983 Feb; 728(1):31-8. PubMed ID: 6299338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.
    Fryklund J; Wallmark B
    J Pharmacol Exp Ther; 1986 Jan; 236(1):248-53. PubMed ID: 3001289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Substituted methoxybenzyl-sulfonyl-1H-benzo[d]imidazoles evaluated as effective H
    Rajesh R; Manikandan A; Sivakumar A; Ramasubbu C; Nagaraju N
    Eur J Med Chem; 2017 Oct; 139():454-460. PubMed ID: 28818769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on the mechanisms of gastric acid secretion.
    Kopic S; Geibel JP
    Curr Gastroenterol Rep; 2010 Dec; 12(6):458-64. PubMed ID: 20821079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pharmacology of the gastric acid pump: the H+,K+ ATPase.
    Sachs G; Shin JM; Briving C; Wallmark B; Hersey S
    Annu Rev Pharmacol Toxicol; 1995; 35():277-305. PubMed ID: 7598495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438).
    Shin JM; Inatomi N; Munson K; Strugatsky D; Tokhtaeva E; Vagin O; Sachs G
    J Pharmacol Exp Ther; 2011 Nov; 339(2):412-20. PubMed ID: 21828261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
    Fujisaki H; Oketani K; Shibata H; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Takeguchi N
    Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between acid secretion and proton pump activity during inhibition by the proton pump inhibitors omeprazole and pantoprazole.
    Nishioka K; Nagao T; Urushidani T
    Biochem Pharmacol; 1999 Oct; 58(8):1349-59. PubMed ID: 10487539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between gastric acid secretion and gastric H+,K+-ATPase activity.
    Wallmark B; Larsson H; Humble L
    J Biol Chem; 1985 Nov; 260(25):13681-4. PubMed ID: 2997178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of stilbene derivatives on gastric H+, K(+)-ATPase.
    Murakami S; Arai I; Muramatsu M; Otomo S; Baba K; Kido T; Kozawa M
    Biochem Pharmacol; 1992 Nov; 44(10):1947-51. PubMed ID: 1333200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Properties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties.
    Parsons ME; Rushant B; Rasmussen TC; Leach C; Ife RJ; Postius S; Pope AJ
    Biochem Pharmacol; 1995 Nov; 50(10):1551-6. PubMed ID: 7503756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.